Authors' Reply: Megavitamin Treatment of Schizophrenia
Dear Sir:
We envy Doctors Abram and his namesake John Hoffer's indefatigable capacity to write polemic letters, a capacity which we are unable to match. We started our series of controlled megavitamin trials in schizophrenic patients nine years ago, with the sincere hope that we might obtain at least some positive results. Alas, so far the facts have turned out to be different.
Dr. John Hoffer states in his letter to the editor, that in one of our publications (Int. J. Clin. Pharmacol. 5, 4: 406-410, 1972) we have claimed that there were significant differences in the increased amounts of chlorpromazine required for niacin and niacinamide-treated patients as compared to those receiving placebo. We never claimed that these differences were statistically significant, only that they -and other differences, such as days spent in hospital, and so on, pointed consistently in the wrong direction and that they were definitely not suggesting any therapeutic effect.
In fact, as time went on we became rather disturbed that not even one of the megavitamin-treated patients ever showed a dramatic or even notable improvementsomething which every clinician expects to see eventually whenever more than 50 patients are treated over any length of time, regardless of the nature of the hypothesized therapeutic agent.
In the niacin-methionine trial to which J. Hoffer refers, we did not consider the possibility that sex differences are responsible for the patients becoming worse on niacin in the cross-over trial, because each group deteriorated clinically to some extent every time niacin was introduced into the treatment, with the exception of one group once -immediately following the withdrawal of neuroleptic drugs.
Dr. J. R. Wittenborn had not yet published his latest paper in which he formulates a hypothesis about a possible therapeutic action of niacin when we wrote our report. Nevertheless, our statement remains valid in that in Wittenborn's material most of the comparisons regarding home and community adjustment were more favourable in the control group than in the niacin group.
Finally, Dr. J. Hoffer is in error when he states that we did not employ ascorbic acid in out studies. We did use it in the amount of 1000 mg per day in a recent study and the results, which have not yet been reported, do not appear to be very favourable.
Psychiatric Manpower in Canada
Dear Sir: In my paper "Psychiatrists and psychiatry residents in Canada" (4) 1 compared the number of residents in training (459) in the fall of 1973 with the number of psychiatrists (1,614), and stated that if this ratio was sustained it would produce a doubling of the number of psychiatrists in Canada in fourteen years. However, such a statement made a number of assumptions which were unlikely to be correct as the data were incomplete.
I also pointed to the dominance in numbers of two university departments. In the fall of 1973 McGill University was training 20.5 percent and the University of Toronto 24.8 percent of all Canadian psychiatry residents. In view of this the paper by Steiner et al., (3) relating to University of Toronto psychiatry residents is of considerable interest. These authors, in studying the outcome of training of psychiatry residents there, found that during the six-year period, 1966-1971, of the 142 residents who had terminated psychiatry residency, 71 (50 percent) had become certified psychiatrists, 38 (26.8 percent) completed the course but were not certified and 33 (23.2 percent) did not complete their training. The dropouts were a heterogeneous group and some left after two or more years training (frequently with poor supervisor ratings), while others left after one year (often with good ratings) probably because they felt that psychiatry was not for them.
Clearly, if other university psychiatry departments are having comparable experiences with their residents, then my figures relating to the total number of residents in training must be interpreted with caution, and certain allowances must be made.
The following updates some of the information given in my original paper:
• This information relating to the Province of Quebec was provided by the Professional Corporation of Physicians of that province: Only a minority of successful candidates in the written part postponed taking the oral. Furthermore it is clear that the examination is not in two separate independent parts, since the candidate must pass the first part before being allowed to proceed to the second. I have therefore attempted to produce figures which may approximately correspond in terms of the percentage pass rate to those given for the years before 1973 in Table IV 
